| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/21/2002 | WO2001081545A3 Regulation of gene expression by hspbp1 |
| 03/21/2002 | WO2001079432A3 A novel polypeptide, a human cell differentiation transcription factor 58 and the polynucleotide encoding the polypeptide |
| 03/21/2002 | WO2001079257A3 Multidrug resistance (mdr) efflux pump polypeptides |
| 03/21/2002 | WO2001077376A8 Diagnosis of diseases associated with metastasis |
| 03/21/2002 | WO2001077289A3 Polynucleotides encoding novel secreted proteins |
| 03/21/2002 | WO2001077288A3 Polynucleotides encoding novel secreted proteins |
| 03/21/2002 | WO2001077164A8 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 03/21/2002 | WO2001077159A3 An endogenous ketogulonigenium plasmid |
| 03/21/2002 | WO2001075041A3 A novel polypeptide-human epilepsy-associated protein 11 and the polynucleotide encoding said polypeptide |
| 03/21/2002 | WO2001075003A3 A NOVEL POLYPEPTIDE, A HUMAN UTERUS PROTEIN ASSOCIATED WITH A cpn 60 26 MOLECULE AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 03/21/2002 | WO2001074994A3 A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001074847A3 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer |
| 03/21/2002 | WO2001074379A3 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001068854A3 Fibroblast growth factor-like molecules and uses thereof |
| 03/21/2002 | WO2001068829A3 Genetically stable cholera vaccines |
| 03/21/2002 | WO2001068818A3 Hcv ns2/3 fragments and uses thereof |
| 03/21/2002 | WO2001068701A3 Regulation of human seven transmembrane - like g protein - coupled receptor (7tm-gpcr) |
| 03/21/2002 | WO2001068700A3 Regulation of human substance p-like g protein-coupled receptor |
| 03/21/2002 | WO2001066748A3 Full length expressed human polynucleotides and the polypeptides they encode |
| 03/21/2002 | WO2001066743A3 A potassium channel molecule and uses therefor |
| 03/21/2002 | WO2001064923A3 Vire2-mediated trans-membrane delivery systems |
| 03/21/2002 | WO2001064894A3 Human phospholipid scramblase-like molecules and uses thereof |
| 03/21/2002 | WO2001064890A3 Novel defense induced genes and uses thereof |
| 03/21/2002 | WO2001064840A8 Novel bone marrow nucleic acids and polypeptides |
| 03/21/2002 | WO2001064837A3 β NETRIN AND USES THEREOF |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001051513A3 Ovarian tumor-associated sequences |
| 03/21/2002 | WO2001051510A3 G-csf conjugates |
| 03/21/2002 | WO2001047952A3 Insecticidal proteins from bacillus thuringiensis |
| 03/21/2002 | WO2001044275A3 Processes and organisms for the production of anti-freeze proteins |
| 03/21/2002 | WO2001042295A3 Clasp-7 transmembrane protein |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001040302A3 Organ transplant rejection and associated conditions |
| 03/21/2002 | WO2001040275A3 Peptides that stabilize protein antigens and enhance presentation to cd8+ t cells |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001036635A3 Neurite outgrowth-promoting factor homologue and nucleic acids encoding same |
| 03/21/2002 | WO2001032872A3 Twik potassium channel molecules and uses therefor |
| 03/21/2002 | WO2001031009A3 Chandra: a th1-specific gene |
| 03/21/2002 | WO2001012855A3 Binary encoded sequence tags |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | US20020035738 Plant protection method |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035244 Reagents and methods useful for detecting diseases of the prostate |
| 03/21/2002 | US20020035241 Process for the separation and/or isolation of plasma proteins by means of annular chromatography |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035239 Active materials for grampositive bacteria, antibiotic resistance infections |
| 03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
| 03/21/2002 | US20020035080 Proliferation potential proteins (P2P), involved in RNA processing; repressing the proliferative potential of a cell with an antisense oligonucleotide that binds to a domain of the open reading frame of P2P cDNA |
| 03/21/2002 | US20020035062 Process for the preparation of a protein solution |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035060 Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer |
| 03/21/2002 | US20020035056 54420, a novel human calcium channel |
| 03/21/2002 | US20020034822 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 03/21/2002 | US20020034809 Process for producing a plasma protein-containing medicament |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034804 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034802 Crystals of the alpha 1 beta 1 integrin I-domain and their use |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034799 Nucleotide sequences coding transport polypeptide; for use in gene therapy |
| 03/21/2002 | US20020034789 Isolated proteins containing portions of fapalpha and other proteins |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034785 Nucleotide sequences coding preferential binding protein for use in the treatment of bacterial, fungal, protozoan and viral infections; pain; cancers; eating, nervous system, psychological and cardiovascular disorders |
| 03/21/2002 | US20020034784 Novel molecules of the card-related protein family and uses thereof |
| 03/21/2002 | US20020034781 Nucleotide sequences coding membrane protein for use in treatment and diagnosis of pain defects |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034771 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 03/21/2002 | US20020034769 Novel glycolipid complexes and their uses |
| 03/21/2002 | US20020034768 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034751 Aspergillus fumigatus antigenic protein 1 |
| 03/21/2002 | US20020034749 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034740 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034739 Peptides characteristic of certain tumors |
| 03/21/2002 | US20020034738 Human vascular ibp-like growth factor |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034735 Applying mixed solution comprising adenovirus and undesired type of biomolecule to anion exchange chromatography resin containing binding moiety such as dimethylaminopropyl such that adenovirus binds to resin, eluting |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034732 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 03/21/2002 | US20020034726 Modulators for amplifying chemotaxis; for use in the treatment of allergic defects; for use in treatment of tumors |
| 03/21/2002 | US20020034559 E. coli extract for protein synthesis |
| 03/21/2002 | US20020034523 Immunogenic preparation and method for improving the productivity of ruminant animals |
| 03/21/2002 | US20020034521 Botulinum neurotoxin vaccine |
| 03/21/2002 | US20020034516 Test kits; genetic engineering |
| 03/21/2002 | US20020034515 Proteus mirabilis-based vaccine |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034510 Genetic engineered protein; antiischemic agents |